Skip to product information
1 of 1

  • Images are for illustration purposes only
  • Gphc Registered
  • Join over 100k customers
  • Fixed prices and no subscriptions
  • Discreet next day delivery.
  • Free shipping on all orders over £50

Telfast Antihistamine Tablets 180mg Tablets (30)

Telfast Antihistamine Tablets 180mg Tablets (30)

  • 1. Ozempic®️-equivalent therapy now available for weight management
  • 2. Average weight loss of 17%, with 1 in 3 patients achieving over 20%
  • 3. May help reduce osteoarthritis-related pain
  • 4. Wegovy®️ is not expected to impact the effectiveness of oral contraceptives
  • 5. Supports cardiovascular risk reduction
  • 6. Over 22 million patients treated with semaglutide-based therapies since 2018

We’re proud to offer fast and discreet delivery for all our medicines & treatments.

Price Checker

Regular price £19.99
Sale price £19.99
Sale Sold out
  • Lowest price guarantee
  • Includes FREE private prescription
View full details

Buy Telfast Antihistamine Tablets 180mg Tablets (30) Online In The UK

 

Telfast 180mg Tablets are used to provide strong, fast-acting relief from symptoms of hay fever (itchy watery eyes, sneezing, and runny nose) and itchy skin rash or hives. Each tablet contains fexofenadine hydrochloride, a non-drowsy antihistamine that targets allergy symptoms with maximum strength without the drowsiness associated with other antihistamines. 

 


This high-potency formula for adults is ideal for adults who need reliable daily allergy control, helping ease symptoms like sneezing, itchy nose or throat, runny nose, and red or watery eyes. Telfast 180mg is also commonly used to treat allergic skin conditions such as chronic idiopathic urticaria (hives), helping reduce itching and the appearance of raised, red patches on the skin. 

 


Telfast is a fast-acting medication that many people find helps within an hour of taking their dose. It also has a longer duration of action and is less likely to cause drowsiness than older antihistamines, making it perfect for the workday, school, and other activities. 

 


If you suffer from allergies with mild to severe symptoms and are looking for relief, Telfast 180mg is a trusted choice that provides long-lasting relief. 

How To Use Telfast Antihistamine Tablets 180mg Tablets (30)


Taking one Telfast 180mg tablet per day will provide relief. It should be taken before having food, every day at the same time, in order to manage the symptoms. 


Swallow the tablet whole. Do not break or chew it. If you have seasonal allergies, take Telfast regularly during the high-pollen days so that you can get relief consistently. For hives or chronic symptoms, take the medication every day for as long as your healthcare provider recommends. 


Avoid taking indigestion medicines (antacids containing aluminium or magnesium) within 2 hours of Telfast, as they can reduce how well the medicine is absorbed. 
Never exceed the stated dose. 


Important Usage Tips 


To ensure the best effect, avoid taking antacids containing aluminium or magnesium within 2 hours of your dose, as these can reduce absorption. Continue to take the tablets daily throughout your allergy period or as directed by your prescriber. Do not exceed the stated dose. 

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)

Side Effects Of Telfast Antihistamine Tablets 180mg Tablets (30)

Telfast 180mg is generally well tolerated, but like all medicines, it may cause side effects in some people.

Common side effects (affect up to 1 in 10 people):



• Headache

• Dizziness

• Nausea

• Drowsiness or tiredness

• Dry mouth

Uncommon side effects (affect up to 1 in 100 people):



• Trouble sleeping

• Fast or irregular heartbeat

• Stomach discomfort or indigestion

Rare side effects (affect up to 1 in 1,000 people):



• Severe allergic reactions such as swelling of the face, lips, tongue, or throat

• Difficulty breathing

• Severe skin reactions or rash

Seek urgent medical help if you or your child experiences signs of a serious allergic reaction.

Patient Information Leaflet

Important - Before taking any medication, it is always important to read the Patient Information Leaflet (PIL)

Written and reviewed by our qualified team

GPhC Number: 2233073
Tarun Kumar

Reviewed by:

Tarun Kumar

Superintendent/ Clinical Lead

📖 Find out more about our team of medical content authors and how we ensure the accuracy of our content with our content guidelines.

Content last updated: 31 Mar 2025

We’re a safe and
regulated UK service

Registered Pharmacy Badge

Lowest Price Guarantee

We're convinced you won't find your treatment cheaper, but if you do we'll refund the difference.

Find out more

100% discreet packaging

We're convinced you won't find your treatment cheaper, but if you do we'll refund the difference.

Find out more

Agent

Need help?
Talk to our friendly experts now

How our service works

Service Setup

Service setup

Discreet Packaging

Discreet packaging

Express Delivery

Express delivery

Comparison of Weight Loss Injectables

Features

Mounjaro®

Injectable Pen

Wegovy®

Injectable Pen

Saxenda®

Injectable Pen

Active Ingredient Tirzepatide Semaglutide Liraglutide
Mechanism of Action GLP-1 and GIP receptor agonist GLP-1 receptor agonist GLP-1 receptor agonist
Administration Weekly injection Weekly injection Daily injection
Dosage Varies by patient, typically starting low Varies, typically starting at 0.25 mg Varies, starting at 0.6 mg
Effect on Appetite Significantly reduces appetite and cravings Reduces appetite and increases satiety Reduces appetite and increases satiety
Average Weight Loss Up to 20% body weight reduction Up to 15% body weight reduction Significant weight reduction
Side Effects Nausea, vomiting, diarrhoea, constipation Nausea, vomiting, diarrhoea, constipation Nausea, diarrhoea, constipation, hypoglycemia
Approval FDA-approved for weight loss FDA-approved for weight loss FDA-approved for weight loss
Suitable For Adults with BMI ≥30 or ≥27 with comorbidities Adults with BMI ≥30 or ≥27 with comorbidities Adults with BMI ≥30 or ≥27 with comorbidities